Scapa Group PLC Trading Statement (2425T)

TIDMSCPA

RNS Number : 2425T

Scapa Group PLC

11 October 2017

11 October 2017

Scapa Group plc ("Scapa" or "the Group")

Period end update

Scapa Group plc (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive based products for the Healthcare and Industrial markets, is today providing a period end update for the six months ended 30 September 2017.

Group revenue, trading profits* and margins are all ahead of last year. Results include the benefit from currency against the equivalent period last year, and a full contribution from Euromed, acquired in May 2016.

Healthcare sales grew 7.9%, or 2.1% at constant exchange rates, with improvement in both trading profit and margins.

Industrial continues to benefit from the margin improvement programs. During the period the Group successfully completed the sale of the Rorschach property in Switzerland for CHF17.1m (GBP13.6m), and acquired Markel Industries for US$10m (GBP7.8m).

We remain confident of strong progress for the year, and we anticipate the profit for the year will be ahead of current expectations.

The Group will release its results for the half year on 21 November 2017.

*Before exceptional items, amortisation of intangible assets and legacy pensions costs and finance charges

Enquiries:

 
 Scapa Group plc 
  Heejae Chae - Chief Executive 
  Graham Hardcastle - Finance 
  Director                            0161 301 7430 
 
   Numis Securities Limited 
   (Nominated Adviser) 
   Mark Lander / Richard 
   Thomas                             020 7260 1000 
 
   Berenberg 
   (Joint Broker) 
   Chris Bowman                       020 3207 7800 
 
   Weber Shandwick 
   Nick Oborne                        020 7067 0721 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTOKKDKABDDOKD

(END) Dow Jones Newswires

October 11, 2017 02:00 ET (06:00 GMT)